The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy

(2011) Gabriele D Maurer et al.   BMC CANCER

[2,4-13C]β-hydroxybutyrate Metabolism in Astrocytes and C6 Glioblastoma Cells

(2011) Haytham Eloqayli et al.   NEUROCHEMICAL RESEARCH

Mitochondrial response to controlled nutrition in health and disease

(2011) Manuel Schiff et al.   NUTRITION REVIEWS

Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma

(2011) Tiernan J. Mulrooney et al.   PLoS One

Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges

(2011) M. Kelly Nicholas et al.   SEMINARS IN ONCOLOGY

Mitochondrial Energetics and Therapeutics

(2010) Douglas C. Wallace et al.   Annual Review of Pathology-Mechanisms of Disease

Ketones and lactate “fuel” tumor growth and metastasis

(2010) Gloria Bonuccelli et al.   CELL CYCLE

Current and emerging molecular targets in glioma

(2010) Rafael Roesler et al.   Expert Review of Anticancer Therapy

The importance of mitochondria in the tumourigenic phenotype: Gliomas as the paradigm (Review)

(2010) Liang   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Does the existing standard of care increase glioblastoma energy metabolism?

(2010) Thomas N Seyfried et al.   LANCET ONCOLOGY

The ketogenic diet changes metabolite levels in hippocampal extracellular fluid

(2010) Ramakrishna Samala et al.   NEUROCHEMISTRY INTERNATIONAL

Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report

(2010) Giulio Zuccoli et al.   Nutrition & Metabolism

The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma

(2010) Phillip Stafford et al.   Nutrition & Metabolism

Therapeutic options for recurrent malignant glioma

(2010) Maximilian Niyazi et al.   RADIOTHERAPY AND ONCOLOGY

Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy

(2009) BS Dwarakanath et al.   Future Oncology

Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors

(2009) BS Dwarakanath et al.   Journal of Cancer Research and Therapeutics

Availability of neurotransmitter glutamate is diminished when β-hydroxybutyrate replaces glucose in cultured neurons

(2009) Trine M Lund et al.   JOURNAL OF NEUROCHEMISTRY

Ketone bodies inhibit the viability of human neuroblastoma cells

(2009) Robert Skinner et al.   JOURNAL OF PEDIATRIC SURGERY

Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells

(2009) Hui-Fang Li et al.   Radiation Oncology

The ketogenic diet: Uses in epilepsy and other neurologic illnesses

(2008) Kristin W. Barañano et al.   Current Treatment Options in Neurology

Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet

(2008) Jeremy Marsh et al.   Nutrition & Metabolism

A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth

(2008) M. Ralser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis

(2008) R. Brooks Robey et al.   SEMINARS IN CANCER BIOLOGY